Drug Trial Radar · NCT06986772
TGRX-678 Pharmacokinetic Mass Balance
Last checked: Nov 19, 2026Latest source record: Sep 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Jul 7, 2025
Primary completion
Aug 17, 2025
Study completion Aug 25, 2025
Sponsor
- Lead sponsor
- Shenzhen TargetRx Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- The First Affiliated Hospital of Soochow University
- First posted
- May 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a pharmacokinetic study for \[14C\]TGRX-678 on mass balance to evaluate distribution, metabolism and excretion of TGRX-678, a tyrosine kinase inhibitor indicated for treatment of chronic myeloid leukemia.
Conditions
- Chronic Myeloid Leukemia
Interventions
[14C]TGRX-678Drug
Healthy subjects will be given TGRX-678 240 mg orally on day 1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Urine radioactivityTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Fecal radioactivityTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Plasma AUC (Area under curve) percentageTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Urine %DoseTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Fecal %DoseTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Plasma CmaxTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Plasma TmaxTime frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
- Plasma AUC(0-t)Time frame: Day-1 (day before dosing), Day 1 to Day 54 after dosing
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.